Advantages and drawbacks of the Zelen design for randomized clinical trials.
作者信息
Horwitz R I, Feinstein A R
出版信息
J Clin Pharmacol. 1980 Jul;20(7):425-7.
PMID:7430410
Abstract
摘要
相似文献
1
Advantages and drawbacks of the Zelen design for randomized clinical trials.
J Clin Pharmacol. 1980 Jul;20(7):425-7.
2
Advantages and drawbacks of the Zelen design for randomized clinical trials.
J Clin Pharmacol New Drugs. 1980 Jul;20(7):425-7.
3
Randomization and efficiency in Zelen's single-consent design.
Biometrics. 1987 Dec;43(4):885-94.
4
Randomized clinical trials and research strategy.
Cancer Treat Rep. 1982 May;66(5):1083-7.
5
Historical controls, data banks, and randomized trials in clinical research: a review.
Cancer Treat Rep. 1982 May;66(5):1101-5.
6
Strategy and alternate randomized designs in cancer clinical trials.
Cancer Treat Rep. 1982 May;66(5):1095-100.
7
A new design for randomized trials.
N Engl J Med. 1979 Oct 4;301(14):786.
8
The relative efficiency of Zelen's prerandomization design for clinical trials.
Biometrics. 1983 Sep;39(3):711-8.
9
A new design for randomized trials.
N Engl J Med. 1979 Oct 4;301(14):786-7.
10
A new design for randomized trials.
N Engl J Med. 1979 Oct 4;301(14):786.
引用本文的文献
1
Methodological choices for the clinical development of medical devices.
Med Devices (Auckl). 2014 Sep 23;7:325-34. doi: 10.2147/MDER.S63869. eCollection 2014.
2
Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol.
Antimicrob Agents Chemother. 1992 Mar;36(3):620-5. doi: 10.1128/AAC.36.3.620.
Zotero 插件